As CEO and Managing Director, he demonstrates his strong leadership and business acumen by identifying the potential for growth in the pharmaceutical industry and negotiating the purchase of a South African Health Products Regulatory Authority (SAHPRA) approved licensed facility. This acquisition provides the company with a strategic advantage in the market, as they are able to produce and distribute pharmaceutical products in compliance with SAHPRA regulations. As the head of the pharmaceutical business, he oversees the day-to-day operations of the company, ensuring that the business is running efficiently and effectively. He develops and implements strategies to optimize the company’s profitability, manage risks, and maintain compliance with regulatory requirements. Under his leadership, the company successfully navigates the challenges of the pharmaceutical industry, including increasing competition, changing regulations, and evolving customer needs. He builds a strong team of professionals and fosters a culture of collaboration and innovation, enabling the company to achieve its goals and objectives. Through his strategic vision and effective management, he positions the company as a leader in the pharmaceutical industry, contributing to its growth and success.
2022-Present | Alphaplant Pharmaceutical
2016 – 2021 | EPI Consult
2017-2020 | Mmed Distribution